{
    "clinical_study": {
        "@rank": "23201", 
        "arm_group": [
            {
                "arm_group_label": "Oral medication treatment", 
                "arm_group_type": "No Intervention", 
                "description": "type 2 diabetics with only oral medications"
            }, 
            {
                "arm_group_label": "Oral medication plus BMMCT", 
                "arm_group_type": "Experimental", 
                "description": "Collect mononuclear cells from bone marrow aspiration, administer to pancreas via selective catheterization to splenic artery."
            }, 
            {
                "arm_group_label": "Oral medication plus insulin treatment", 
                "arm_group_type": "No Intervention", 
                "description": "Type 2 diabetics who need insulin therapy with oral medications"
            }, 
            {
                "arm_group_label": "Oral medication plus insulin plus BMMCT", 
                "arm_group_type": "Experimental", 
                "description": "Collect mononuclear cells from bone marrow aspiration, administer to pancreas via selective catheterization to splenic artery."
            }
        ], 
        "brief_summary": {
            "textblock": "The study is aimed to evaluate the safety and efficiency of autologous bone marrow\n      mononuclear cell transplantation in treating selective patients with type 2 Diabetes\n      Mellitus. We hypothesized that autologous bone marrow stem cell transplantation would\n      promote \u03b2-cells regeneration by directly differentiated from the transplanted BMMCs or\n      stimulate local stem cells regeneration and thus decrease or eliminate the need of exogenous\n      insulin and improve \u03b2-cells function."
        }, 
        "brief_title": "Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "detailed_description": {
            "textblock": "To study the safety and efficacy of bone marrow mononuclear cell transplantation in type 2\n      diabetics. According to the intervention and baseline characteristics, patients are divided\n      into 4 arms."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Type 2 diabetes mellitus\n\n          -  age 30-70\n\n          -  stable doses of medication for at least 3 months\n\n          -  BMI <35 and >18.5\n\n        Exclusion Criteria:\n\n          -  secondary cause for hyperglycemia\n\n          -  pregnancy or nursing\n\n          -  positive autoimmune antibody of diabetes\n\n          -  severe complication or concurrent diseases\n\n          -  active infection or febrile illness\n\n          -  allergy to iodine\n\n          -  history or signs of aortic aneurysm\n\n          -  history or active pancreatic diseases\n\n          -  known substance abuse or alcoholism or heavy smoking\n\n          -  not suitable for other conditions upon investigators' expertise"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01677013", 
            "org_study_id": "PUACH-721002"
        }, 
        "intervention": {
            "arm_group_label": [
                "Oral medication plus BMMCT", 
                "Oral medication plus insulin plus BMMCT"
            ], 
            "description": "Bone marrow mononuclear cell transplantation via selective catheterization", 
            "intervention_name": "BMMCT", 
            "intervention_type": "Other", 
            "other_name": "Bone marrow mononuclear cell transplantation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Type 2; diabetes mellitus; stem cell; safety; efficacy", 
        "lastchanged_date": "August 30, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100049"
                }, 
                "name": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital"
            }, 
            "investigator": {
                "last_name": "Lei Lei, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "4", 
        "official_title": "Efficacy of Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Selective Type 2 Diabetes Mellitus", 
        "overall_contact": {
            "email": "leileihospital@gmail.com", 
            "last_name": "Lei Lei, M.D.", 
            "phone": "+86-10-59971870"
        }, 
        "overall_official": [
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Yizhong Wang, M.D., Ph.D.", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Department of Biochemisty, National Cerebral and Cardiovascular Center; Department of Cardiology, China-Japan Friendship Hospital", 
                "last_name": "Yuanjie Mao, M.D., Ph.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Lei Lei, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Danping Meng, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Xiyang Zhang, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Xiaolin Jia, M.D.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Qiuming Jiang, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Yufang Li, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Song Dong, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Liyan Yang, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Hong Wang, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Mingchao Ding, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Liqin Cui, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Bin Wang, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Xin Lin, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Division of Hematology and Endocrinology, Peking University Aerospace Centre Hospital", 
                "last_name": "Han Shi, M.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "C-peptide", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01677013"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University Aerospace Centre Hospital", 
            "investigator_full_name": "Lei Lei, MD", 
            "investigator_title": "Endocrinologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "reduction of medication", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "HbA1c", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Peking University Aerospace Centre Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University Aerospace Centre Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}